Craig Kraffert, MD
Dermatology · Redding, CANPI 1053300632
Payments from drug & device makers
Across 1,348 payments — averaging $494.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$181K
- AbbVie$129K
- Janssen Scientific Affairs, LLC$116K
- UCB, Inc.$87K
- Johnson & Johnson$70K
- Galderma Laboratories, L.p.$53K
- plus $31K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 309 | $181,460 |
| AbbVie(2 entities) | 315 | $128,554 |
| Janssen Scientific Affairs, LLC | 88 | $115,709 |
| UCB, Inc. | 116 | $87,015 |
| Johnson & Johnson | 121 | $69,639 |
| Galderma Laboratories, L.p. | 46 | $53,093 |
| Arcutis Biotherapeutics, Inc. | 48 | $17,538 |
| E.r. Squibb & Sons, L.L.C. | 18 | $3,854 |
| Janssen Research & Development, LLC | 3 | $1,584 |
| Novartis | 75 | $1,468 |
| Incyte Corporation | 43 | $1,323 |
| LEO Pharma Inc. | 42 | $1,076 |
| Sanofi | 42 | $1,043 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 20 | $793 |
| Amgen | 8 | $555 |
| Dermavant Sciences, Inc. | 11 | $368 |
| Regeneron Healthcare Solutions, Inc. | 13 | $279 |
| Journey Medical Corporation | 1 | $278 |
| Regeneron | 5 | $186 |
| Sun Pharmaceutical Industries Inc. | 7 | $135 |
| Genentech USA, Inc. | 7 | $124 |
| GSK | 2 | $72 |
| Medtronic | 1 | $66 |
| Botanix SB Inc | 2 | $33 |
| Pfizer | 1 | $17 |
| Organon | 1 | $16 |
| Almirall LLC | 1 | $13 |
| Prugen, Inc. Pharmaceuticals | 2 | $7 |
How this compares
$666,297 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Redding
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Raja SivamaniSacramento$11.8M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Paul YamauchiSanta Monica$7.8M
- Navid EzraThousand Oaks$7.8M
- Paul WallaceBeverly Hills$7.1M
- April ArmstrongLos Angeles$6.2M
- David RayhanHuntington Beach$5.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.